Stock A054950 JVM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials JVM Co., Ltd.

Equities

A054950

KR7054950001

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-23 EDT 		5-day change 1st Jan Change
28,650 KRW -1.88% Intraday chart for JVM Co., Ltd. -1.55% +8.11%
03-12 JVM Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 JVM Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 172,810 207,035 160,676 235,542 305,226 329,990 - -
Enterprise Value (EV) 2 164.6 207 130.9 199.2 247.7 235.2 205 330
P/E ratio - - - 14.9 x 11.6 x 11.3 x 9.72 x 9.35 x
Yield 1.35% 1.11% 1.43% 1.47% 1.51% 1.57% 1.66% 1.92%
Capitalization / Revenue 1.57 x 1.79 x 1.39 x 1.66 x 1.94 x 1.87 x 1.68 x 1.59 x
EV / Revenue 1.49 x 1.79 x 1.13 x 1.4 x 1.58 x 1.34 x 1.05 x 1.59 x
EV / EBITDA - - 7.74 x 7.39 x 7.14 x 5.77 x 4.34 x 6.47 x
EV / FCF 11.9 x - 5.62 x 17 x 9.08 x 8.17 x 6.88 x 9.71 x
FCF Yield 8.39% - 17.8% 5.87% 11% 12.2% 14.5% 10.3%
Price to Book 1.4 x 3.02 x 1.12 x 1.49 x 1.7 x 1.62 x 1.44 x 1.2 x
Nbr of stocks (in thousands) 11,676 11,518 11,518 11,518 11,518 11,518 - -
Reference price 3 14,800 17,975 13,950 20,450 26,500 28,650 28,650 28,650
Announcement Date 20-02-04 21-01-29 22-01-27 23-01-27 24-01-31 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 110.1 115.4 115.8 142 157.1 176 195.8 207
EBITDA 1 - - 16.92 26.93 34.68 40.77 47.27 51
EBIT 1 10.46 15.7 12.5 21.99 29.77 35.73 41.6 47
Operating Margin 9.5% 13.61% 10.79% 15.49% 18.95% 20.3% 21.24% 22.71%
Earnings before Tax (EBT) 1 8.37 - - 21.28 33.1 37.97 44.13 46
Net income 1 5.8 - - 15.76 26.24 30.53 35.5 37
Net margin 5.27% - - 11.1% 16.71% 17.34% 18.13% 17.87%
EPS 2 - - - 1,368 2,278 2,537 2,947 3,065
Free Cash Flow 3 13,811 - 23,285 11,697 27,265 28,800 29,800 34,000
FCF margin 12,539.07% - 20,103.29% 8,238.92% 17,356.6% 16,358.99% 15,215.73% 16,425.12%
FCF Conversion (EBITDA) - - 137,649.75% 43,431.54% 78,627.94% 70,645.95% 63,046.54% 66,666.67%
FCF Conversion (Net income) 238,121.4% - - 74,238.74% 103,890.89% 94,323.15% 83,943.66% 91,891.89%
Dividend per Share 2 200.0 200.0 200.0 300.0 400.0 450.0 475.0 550.0
Announcement Date 20-02-04 21-01-29 22-01-27 23-01-27 24-01-31 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 30.58 34.33 - 37.01 34.17 39.29 37.66 38.72 36.85 43.87 40.16 42.2 44.3 46.6
EBITDA - - - - - - - - - - - - - -
EBIT 1 3.514 4.012 - 5.913 5.686 5.96 7.509 6.557 5.823 9.882 7.319 8.1 9.2 10.6
Operating Margin 11.49% 11.69% - 15.98% 16.64% 15.17% 19.94% 16.94% 15.8% 22.53% 18.22% 19.19% 20.77% 22.75%
Earnings before Tax (EBT) 1 - - - - - - - 7.301 6.802 10.84 9.046 8.6 9.8 11.3
Net income 1 - - 3.652 - - - - 3.334 5.367 10.69 8.261 6.9 7.9 9
Net margin - - - - - - - 8.61% 14.57% 24.36% 20.57% 16.35% 17.83% 19.31%
EPS - - 317.0 - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 21-10-28 22-01-27 22-05-13 22-07-28 22-10-27 23-01-27 23-04-27 23-07-27 23-10-26 24-01-31 24-04-30 - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 8.23 - 29.8 36.4 57.5 94.8 125 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 2 13,811 - 23,285 11,697 27,265 28,800 29,800 34,000
ROE (net income / shareholders' equity) 4.7% 8% 6.37% 10.4% 15.5% 15.9% 15.7% 14.9%
ROA (Net income/ Total Assets) - - 4.36% 7.12% 10.7% 11.2% 12.1% 10.7%
Assets 1 - - - 221.4 244.6 271.8 293.4 345.8
Book Value Per Share 3 10,581 5,949 12,458 13,728 15,584 17,650 19,951 23,800
Cash Flow per Share 3 1,589 857.0 2,265 1,282 2,598 2,924 3,138 3,439
Capex 1 4.76 - 2.8 3.07 2.66 3.47 4.2 6
Capex / Sales 4.32% - 2.42% 2.16% 1.69% 1.97% 2.14% 2.9%
Announcement Date 20-02-04 21-01-29 22-01-27 23-01-27 24-01-31 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for JVM Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29,200 KRW
Average target price
36,667 KRW
Spread / Average Target
+25.57%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
JVM CO., LTD. Stock JVM Co., Ltd.
+8.11% 246M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+9.66% 223B
DANAHER CORPORATION Stock Danaher Corporation
+13.19% 194B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+20.29% 141B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.95% 109B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.05% 64.85B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+15.49% 52.7B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+3.96% 51.77B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+7.87% 44.12B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+3.60% 36.21B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. A054950 Stock
  4. Financials JVM Co., Ltd.